Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
A3GALT2	"A3GALT2P, IGB3S, IGBS3S"	ENSG00000184389	"Alpha 1,3-galactosyltransferase 2"	U3KPV4	1	33306766-33321098	"Enzymes, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"HeLa: 5.1;SiHa: 3.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (1.86e-2)"	"unprognostic (2.36e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-3)"		"unprognostic (4.96e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-8)"	"unprognostic (1.17e-1)"		"unprognostic (1.12e-2)"	"unprognostic (7.87e-2)"	0.7	0.1	0.1	1.2	0.2	1.3	0.4	1.3	0.9	0.4	0.2			0.0	0.5	0.0	0.2	0.2	1.4	0.1	0.2	0.1	0.4	0.1	0.5	0.1	0.0		0.4	0.1	0.0	0.4	0.1		0.6	0.0		0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.8	0.3	2.1			0.4		0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	5.1	0.0	0.2	0.0	0.0	0.7	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0										
ABLIM2	KIAA1808	ENSG00000163995	"Actin binding LIM protein family member 2"	Q6H8Q1	4	7965310-8158832	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0;skeletal muscle: 71.8"	"Group enriched"	"Detected in some"	5	"SCLC-21H: 12.9;SiHa: 5.7;U-2197: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 3.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035808	Uncertain		Uncertain	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"HPA035808: AB_10601962"	"unprognostic (7.57e-2)"	"unprognostic (3.24e-3)"	"unprognostic (7.78e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.86e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.32e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.45e-2)"	4.0	3.8	8.2	1.9	19.1	0.8	2.1	4.0	26.0	1.4	2.1	2.3	0.0	1.1	1.2	1.3	10.5	1.4	1.7	5.7	3.4	5.1	2.5	1.2	1.8	1.4	2.8	7.6	1.1	3.3	2.4	6.1	1.2	9.9	1.8	2.1	1.3	2.6	1.2	71.8	3.8	1.8	2.1	1.8	14.8	1.8	1.5	4.0	0.0	2.4	1.9	2.3	1.5	1.7	0.7	0.5	0.0	0.2	0.0	3.0	0.2	1.0	0.0	0.2	1.5	0.4	0.1	0.4	0.0	0.0	0.1	0.0	0.0	1.3	2.8	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.7	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.6	1.9	0.1	0.0	1.1	0.9	0.1	1.0	0.6	0.2	0.0	12.9	1.0	5.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	19.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	1.0	0.1	3.0	0.0	2.5	0.0	0.5	0.7	1.2	0.9	0.0	0.0	0.2	0.0	1.2	0.2	8.2	19.1	4.0	26.0	3.4	5.1	2.8	7.6	9.9	4.0
ALPP		ENSG00000163283	"Alkaline phosphatase, placental"	P05187	2	232378534-232382889	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"placenta: 240.2"	"Group enriched"	"Detected in some"	6	"HaCaT: 86.1;SiHa: 23.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 15.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"CAB026327, HPA038764, HPA038765, HPA051699"	Enhanced		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"		"CAB026327: , HPA038764: , HPA038765: , HPA051699: "		"unprognostic (4.86e-2)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"		"unprognostic (2.60e-1)"		"unprognostic (2.44e-3)"		"unprognostic (1.26e-2)"	"prognostic unfavourable (4.33e-4)"	"unprognostic (1.44e-1)"		"unprognostic (4.09e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.27e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	240.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.5	1.6	0.5	1.1	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	9.7	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	23.7	8.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.7	0.5	0.2	0.5	0.3	0.3	0.3	0.1	1.0	0.4	0.4	1.6	1.1	0.5	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARHGEF33		ENSG00000214694	"Rho guanine nucleotide exchange factor 33"	A8MVX0	2	38889841-38975449	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 42.5"	"Group enriched"	"Detected in some"	4	"BEWO: 8.8;HeLa: 3.9;SiHa: 11.0"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	5	"cerebellum: 42.5"	"Cell type enriched"	"Detected in single"	8	"eosinophil: 6.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.7"	"Region enriched"	"Detected in single"	32	"cerebellum: 314.4"	"Region enriched"	"Detected in many"	11	"cerebellum: 47.0"	"HPA034661, HPA041051"	Enhanced		Supported	Vesicles				Vesicles		"HPA034661: AB_10669679, HPA041051: "	"unprognostic (8.38e-2)"	"unprognostic (7.05e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.99e-1)"	"unprognostic (4.12e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.99e-1)"	0.3	4.0	3.7	1.0	8.6	0.0	1.7	42.5	3.4	2.3	0.7	0.6	0.7	0.1	2.8	5.1	0.7	2.2	1.4	0.8	3.3	3.6	1.4	0.2	1.2	0.5	2.0	2.9	6.8	0.2	2.2	3.5	0.8	3.2	1.7	0.6	0.8	0.4	1.2	0.4	1.3	0.6	1.0	1.5	0.5	0.9	10.1	2.4	0.2	1.4	0.2	0.4	1.2	0.6	0.2	0.1	6.7	0.8	0.0	0.2	0.1	0.3	0.0	0.4	0.2	0.2	0.2	8.8	0.8	0.0	0.0	0.0	0.1	0.2	0.4	0.1	0.8	0.0	0.0	0.0	0.0	1.8	0.9	0.2	3.9	0.3	0.7	0.3	0.3	0.8	0.9	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.9	0.4	0.4	0.3	11.0	0.4	0.0	0.0	0.3	0.6	0.2	1.4	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.1	0.0	0.6	6.7	0.0	0.8	0.1	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	3.7	8.6	42.5	3.4	3.3	3.6	2.0	2.9	3.2	2.4
C11orf86	FLJ22675	ENSG00000173237	"Chromosome 11 open reading frame 86"	A6NJI1	11	66975277-66977004	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	14	"intestine: 57.7"	"Group enriched"	"Detected in some"	5	"HeLa: 6.7;SiHa: 22.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039348	Uncertain									"HPA039348: AB_10673421"		"unprognostic (1.54e-2)"	"unprognostic (7.67e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"prognostic unfavourable (8.97e-4)"		"unprognostic (4.17e-1)"	"prognostic unfavourable (6.97e-5)"		"prognostic unfavourable (1.02e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.58e-3)"	0.1	4.0	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	24.4	0.1	0.1	33.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.5	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	3.0	0.1	0.1	0.1	0.1	0.0	57.7	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.8	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease mutation, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"liver: 611.7"	"Group enriched"	"Detected in many"	7	"BJ hTERT+: 47.4;EFO-21: 99.9;Hep G2: 103.2;HSkMC: 73.7;SiHa: 27.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 1213.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 13.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.2;monocytes: 13.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	1003333333333	250000000000			"CAB004209: AB_627277, HPA003563: AB_1847117, HPA020432: AB_1847118"	"unprognostic (3.26e-3)"	"unprognostic (3.91e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.98e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (8.11e-4)"	"unprognostic (1.99e-1)"	"unprognostic (9.26e-2)"	"unprognostic (5.80e-2)"	"unprognostic (8.12e-3)"	"unprognostic (5.48e-2)"	"prognostic unfavourable (1.09e-5)"	"unprognostic (2.63e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.03e-3)"	"unprognostic (3.88e-1)"	59.7	34.1	9.3	20.0	19.6	1.0	47.3	0.7	10.2	28.3	17.8	13.9	3.7	3.2	9.1	19.9	17.9	38.8	37.9	57.6	7.0	4.1	21.6	611.7	22.6	25.2	12.3	2.2	42.4	22.2	3.1	3.0	2.7	12.8	12.7	9.6	3.9	18.7	7.6	6.8	5.8	15.1	19.1	29.6	1.6	12.6	11.2	10.7	0.1	10.3	3.2	14.1	25.2	38.2	1.2	0.8	4.2	13.3	2.0	0.4	0.8	8.3	3.0	0.0	0.0	1.5	5.0	10.0	0.6	47.4	0.9	1.7	0.5	6.5	0.2	99.9	0.0	6.1	0.0	5.7	0.9	3.0	0.0	0.4	4.4	103.2	2.2	0.8	1.2	73.7	1.7	8.2	3.7	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.0	4.3	0.8	0.0	0.0	27.6	0.0	0.0	2.3	1.1	0.4	0.7	0.9	0.6	0.4	0.2	0.5	0.5	10.2	0.6	0.0	1.7	1.5	0.9	0.4	2.7	0.3	0.7	0.3	0.2	0.8	1.2	0.4	0.4	4.2	2.0	13.3	0.7	0.2	0.8	9.3	19.6	0.7	10.2	7.0	4.1	12.3	2.2	12.8	10.7
GABRQ	THETA	ENSG00000268089	"Gamma-aminobutyric acid type A receptor theta subunit"	Q9UN88	X	152638183-152657534	"FDA approved drug targets, Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 28.9;cervix, uterine: 16.2"	"Group enriched"	"Detected in some"	7	"HeLa: 8.8;SiHa: 8.6;U-87 MG: 28.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"hypothalamus: 61.6"	"Region enhanced"	"Detected in many"		"midbrain: 24.9"												"unprognostic (3.68e-3)"	"unprognostic (7.78e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.17e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.73e-1)"	"unprognostic (3.76e-2)"	"unprognostic (3.10e-5)"	"unprognostic (3.43e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.42e-2)"	"unprognostic (7.70e-2)"	0.2	4.4	10.5	0.2	5.7	0.1	0.1	0.0	7.5	16.2	0.2	1.5	1.0	0.2	2.6	0.5	1.1	0.3	0.1	0.2	23.4		0.2	0.1	0.1	0.2	0.0	13.6	0.1	0.1	0.1	0.0	0.3	28.9	0.9	0.2	0.0	0.1	1.7	0.1	0.7	0.5	1.6	7.2	0.2	0.1	4.7	1.0	0.0	0.3	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.2	0.2	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	2.2	0.0	0.0	0.0	0.0	1.2	8.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
H2BFWT		ENSG00000123569	"H2B histone family member W, testis specific"	Q7Z2G1	X	104011147-104013687	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"testis: 3.2"	"Group enriched"	"Detected in some"	5	"NTERA-2: 1.9;SiHa: 1.0;U-266/84: 3.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056289	Uncertain									"HPA056289: "						"unprognostic (5.07e-2)"				"unprognostic (1.55e-1)"					"unprognostic (1.15e-1)"		"unprognostic (1.85e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.8		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
IL21	"IL-21, Za11"	ENSG00000138684	"Interleukin 21"	Q9HBE4	4	122612628-122621069	"Disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	4	"HeLa: 4.2;Karpas-707: 1.1;SiHa: 3.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	16	"memory CD4 T-cell: 2.2;T-reg: 1.0"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	55657												"unprognostic (2.42e-1)"						"unprognostic (2.12e-1)"	"unprognostic (6.80e-2)"			0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.1	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	3.5			0.1		7.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1										
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619437-41624842	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 109.0;tongue: 144.0"	"Group enriched"	"Detected in some"	7	"hTCEpi: 638.7;SiHa: 265.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"			750000000	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: "	"prognostic favourable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavourable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	0.7	0.0	0.7	0.7	0.7	0.1	52.3	0.7	0.8	12.6	0.8	0.7	1.2	0.0	1.0	3.1	38.6	0.9	0.9	0.7	0.7	0.0	0.8	0.7	3.7	0.7	0.7	1.0	0.8	0.7	0.0	0.9	4.1	0.8	15.0	0.0	0.7	26.8	33.4	0.7	109.0	0.7	1.2	0.7	0.7	0.0	0.8	0.7	5.1	0.8	144.0	19.7	55.6	25.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.4	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	64.6	0.0	66.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.0	0.0	638.7	0.0	49.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	24.2	0.0	0.0	265.9	0.1	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.7	0.7	0.8	0.7	0.0	0.7	1.0	0.8	0.7
KRTAP7-1	KAP7.1	ENSG00000274749	"Keratin associated protein 7-1 (gene/pseudogene)"	Q8IUC3	21	30829039-30829759	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 2.3;skin 1: 1.6;tongue: 3.1"	"Group enriched"	"Detected in some"	8	"SiHa: 3.3;SK-MEL-30: 2.0;WM-115: 2.6"	"Cancer enriched"	"Detected in single"	16	"urothelial cancer: 1.2"					"Cell type enriched"	"Detected in single"	13	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 2.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0										
LLCFC1	"C7orf34, CTM-1"	ENSG00000165131	"LLLL and CFNLAS motif containing 1"	Q96L11	7	142939343-142940868	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"testis: 31.9"	"Group enriched"	"Detected in some"	5	"K-562: 3.1;RT4: 3.3;SiHa: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"														"Intracellular and membrane"						"unprognostic (5.05e-2)"	"unprognostic (9.94e-2)"			"unprognostic (5.49e-3)"			"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.54e-1)"	"unprognostic (2.02e-1)"			0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.8	0.5	0.0	31.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	3.3	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1
MAJIN	C11orf85	ENSG00000168070	"Membrane anchored junction protein"	Q3KP22	11	64937517-64972085	"Predicted intracellular proteins"	Meiosis	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 43.7"	"Group enriched"	"Detected in some"	9	"CAPAN-2: 12.2;SiHa: 5.1"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebellum: 4.9"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.1;naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	5	"B-cells: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (3.37e-1)"	"unprognostic (6.43e-3)"	"unprognostic (3.69e-2)"	"unprognostic (7.05e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.79e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-2)"	0.2	0.2	0.2	1.2	0.7	0.0	0.2	4.9	0.4	0.3	0.2	0.1	0.7	0.0	0.2	2.2	0.2	1.1	2.9	0.4	0.1	0.1	1.4	1.0	0.2	1.5	0.2	0.0	0.1	1.7	0.0	1.5	0.0	0.7	0.3	0.1	0.5	0.3	0.6	0.1	1.2	0.6	0.0	0.2	1.6	0.2	43.7	0.0	0.0	0.8	0.1	1.2	0.3	0.5	4.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.7	0.0	0.0	1.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.7	4.9	0.4	0.1	0.1	0.2	0.0	0.7	0.0
MAOB		ENSG00000069535	"Monoamine oxidase B"	P27338	X	43766611-43882447	"Enzymes, FDA approved drug targets, Predicted membrane proteins"		Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 104.9"	"Group enriched"	"Detected in some"	7	"Hep G2: 20.2;SiHa: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	6	"T-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002328, CAB037200"	Enhanced						3600000			"CAB037200: AB_1841012, HPA002328: AB_1854062"	"unprognostic (1.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.61e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.74e-2)"	"unprognostic (5.35e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.90e-3)"	25.0	18.2	24.8	3.9	34.8	0.5	16.5	5.5	24.5	12.0	18.9	20.3	15.6	24.9	38.0	20.0	11.4	34.9	15.4	32.4	21.2	46.9	41.8	104.9	10.9	2.3	24.4	19.9	56.0	4.1	15.6	8.9	9.4	26.8	30.1	6.3	3.0	38.0	55.9	34.8	3.0	30.5	35.9	39.1	1.3	8.4	5.2	21.3	0.2	1.8	8.2	2.8	12.1	8.5	0.0	0.0	0.0	0.1	0.0	1.0	1.2	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	2.6	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	20.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	1.8	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.5	39.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.2	24.8	34.8	5.5	24.5	21.2	46.9	24.4	19.9	26.8	21.3
NEXMIF	"KIAA2022, KIDLIA, MRX98, XPN"	ENSG00000050030	"Neurite extension and migration factor"	Q5QGS0	X	74732856-74925485	"Disease related genes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.2;parathyroid gland: 9.0"	"Group enriched"	"Detected in some"	9	"HAP1: 6.5;Karpas-707: 10.5;SiHa: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000407	Uncertain		Supported	"Nucleoplasm,Midbody,Mitotic spindle,Cytosol"				Nucleoplasm	"Midbody, Mitotic spindle, Cytosol"	"HPA000407: "	"unprognostic (1.04e-3)"	"unprognostic (6.07e-5)"	"unprognostic (1.81e-2)"	"unprognostic (2.07e-5)"	"unprognostic (2.15e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.37e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.79e-4)"	"unprognostic (6.94e-4)"	0.6	3.0	5.4	0.7	6.2	0.4	1.3	10.2	9.4	1.7	1.9	0.7	1.0	0.6	1.7	0.9	1.8	1.3	0.5	0.3	5.0	6.2	2.4	0.2	0.9	0.5	1.8	5.0	1.7	4.4	9.0	7.5	0.5	1.9	3.2	1.1	1.1	2.5	2.5	0.4	1.8	1.1	2.6	1.2	0.6	1.6	0.9	1.5	0.0	1.5	0.0	0.5	0.7	2.8	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.2	0.3	0.1	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	9.3	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	6.2	10.2	6.8	5.0	6.2	1.8	5.0	1.9	1.5
NPBWR1	GPR7	ENSG00000183729	"Neuropeptides B and W receptor 1"	P48145	8	52938431-52941117	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;brain: 2.8;liver: 2.6"	"Group enriched"	"Detected in some"	5	"A549: 2.2;HaCaT: 2.9;SiHa: 4.5"	"Low cancer specificity"	"Detected in some"							"Group enriched"	"Detected in some"	9	"classical monocyte: 1.6;eosinophil: 3.1"	"Group enriched"	"Detected in many"	9	"granulocytes: 3.1;monocytes: 1.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 10.5"												"unprognostic (2.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.18e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.84e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.71e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.23e-1)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.8	0.8	0.0			0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.1	0.0	2.6	0.0	0.0	0.0		0.0	0.0	0.0	1.5	0.0		0.1	0.0		0.3	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.1			0.0		0.0	1.3	0.1	0.0	0.0	3.1	1.6	0.0	0.2	0.8	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.5	0.3	0.0	4.5	0.1	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.6	3.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.8										
PZP	CPAMD6	ENSG00000126838	"PZP, alpha-2-macroglobulin like"	P20742	12	9148840-9208370	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 56.9"	"Group enriched"	"Detected in some"	8	"HeLa: 9.7;SiHa: 5.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.5;MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 3.5"									"HPA041403, HPA041471"	Supported				"Secreted to blood"		13000000000			"HPA041403: AB_10804003, HPA041471: AB_10795636"	"unprognostic (8.48e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-4)"	"unprognostic (4.79e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.04e-4)"	"unprognostic (4.57e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.81e-3)"	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.8	0.1	0.0	0.7	0.0	0.0	0.9	0.6	0.0	56.9	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	1.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	3.5	0.0	0.7	0.9	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.9	0.6	0.0	0.0	1.4	0.6
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113562	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.1"	"Group enriched"	"Detected in some"	4	"A-431: 8.6;HeLa: 26.3;SiHa: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA057527	Uncertain									"HPA057527: "	"unprognostic (2.75e-2)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	2.9	1.9	3.1	1.7	8.4	4.5	3.9	11.4	4.7	4.6	2.4	4.3	2.0	1.2	2.7	4.3	2.4	4.0	2.1	1.3	2.4	1.6	4.7	0.6	2.9	2.7	3.4	1.1	8.8	13.0	0.8	18.1	1.0	5.3	3.3	1.8	3.6	4.2	1.4	1.9	4.4	1.8	2.2	4.1	1.9	2.6	12.1	2.1	0.5	8.2	1.0	1.9	1.4	3.0	2.1	1.2	0.1	0.7	0.4	3.8	0.9	8.6	0.5	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	3.8	0.1	0.0	2.2	0.0	2.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	2.9	0.0	15.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	2.2	0.7	1.8	0.6	3.8	1.0	1.2	2.1	3.8	1.2	0.0	0.4	0.0	0.4	1.1	0.9	3.1	8.4	11.4	4.7	2.4	1.6	3.4	1.1	5.3	2.1
SEC14L6		ENSG00000214491	"SEC14 like lipid binding 6"	B5MCN3	22	30522799-30546682	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"epididymis: 15.4;parathyroid gland: 20.9"	"Group enriched"	"Detected in some"	4	"K-562: 11.0;RPTEC TERT1: 20.6;SiHa: 6.1"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.6"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA067695			Approved	Nucleoplasm				Nucleoplasm		"HPA067695: "	"unprognostic (3.49e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.25e-2)"	"unprognostic (8.69e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.48e-2)"	"unprognostic (6.02e-2)"	0.7	0.7	3.3	0.0	3.6	1.1	2.4	1.1	2.1	2.3	0.0			0.1	2.0	15.4	0.0	0.9	2.8	0.0	2.4	3.4	7.2	0.0	7.9	0.0	4.0		1.7	3.5	20.9	1.8	0.0		1.0	0.0		0.0	1.6	0.0	7.3	0.0	1.3	3.9	0.0	0.6	3.8			0.0		0.1	0.1	0.0	1.2	0.9	2.7	0.8	1.9	2.2	0.3	0.2	0.1	0.9	0.3	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.2	0.5	0.3	1.0	0.1	0.2	0.1	0.0	0.3	0.0	0.0	2.8	0.3	0.3	0.1	0.2	0.4	0.0	0.1	0.1	0.1	0.0	11.0	0.2	0.0	0.4	0.1	0.4	0.5	0.1	0.2	0.0	0.1	20.6	0.2	0.2	0.1	6.1	0.1	0.0	1.6	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.2	0.0	0.3	0.1	1.9	0.8	0.7	0.6	0.6	1.6	0.7	0.5	0.5	0.2	1.2	0.6	0.9	2.7	1.9	0.7	0.9	2.2	0.3										
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47472168	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.9"	"Group enriched"	"Detected in some"	6	"NTERA-2: 4.3;SCLC-21H: 12.2;SH-SY5Y: 6.6;SiHa: 5.1;U-2 OS: 7.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1"	"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced									"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	1.2	4.0	16.6	1.0	18.1	0.9	0.9	50.9	50.7	1.0	2.4	1.8	1.0	1.3	5.4	1.0	2.3	2.2	1.1	0.9	21.4	6.8	1.0	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1.0	2.0	1.4	1.4	0.0	1.2	4.4	0.9	1.0	1.2	5.5	2.0	1.0	1.3	1.9	1.2	0.0	1.0	0.0	0.9	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.4	0.1	12.2	6.6	5.1	0.6	0.4	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2.0	1.2
SPINK6	"BUSI2, MGC21394, UNQ844"	ENSG00000178172	"Serine peptidase inhibitor, Kazal type 6"	Q6UWN8	5	148202794-148215137	"Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;cervix, uterine: 7.2;tongue: 7.1;vagina: 8.6"	"Group enriched"	"Detected in some"	84	"HeLa: 239.2;SiHa: 114.9"	"Group enriched"	"Detected in many"	6	"cervical cancer: 21.4;head and neck cancer: 21.0"	"Region enriched"	"Detected in single"	78	"cerebellum: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011039	Uncertain				"Secreted - unknown location"					"HPA011039: "		"unprognostic (2.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.87e-2)"	"prognostic favourable (7.16e-4)"		"unprognostic (2.49e-2)"	"unprognostic (4.04e-1)"		"unprognostic (1.80e-2)"	"unprognostic (2.09e-2)"		"unprognostic (2.22e-2)"		"unprognostic (1.29e-2)"	"unprognostic (7.29e-2)"	1.9	1.1	0.1	0.1	0.1	0.0	0.9	10.6	0.1	7.2	1.6	0.1	0.1	0.0	0.1	3.7	5.9	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.6	0.1	0.1	0.8	0.1	5.0	0.2	0.1	0.5	0.1	0.9	0.1	0.1	0.0	0.2	0.1	1.6	0.1	7.1	0.1	0.4	8.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	239.2	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	10.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SPO11	"CT35, SPATA43, TOPVIA"	ENSG00000054796	"SPO11, initiator of meiotic double stranded breaks"	Q9Y5K1	20	57329759-57343994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	Meiosis	"DNA-binding, Hydrolase, Isomerase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	142	"testis: 14.2"	"Group enriched"	"Detected in some"	19	"Daudi: 1.7;SiHa: 1.3;U-698: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306891	"Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 122.8"	"Group enriched"	"Detected in some"	6	"HSkMC: 38.4;SiHa: 36.0;U-2197: 51.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Group enriched"	"Detected in some"	5	"midbrain: 1.7;pons and medulla: 6.4"	"Cell type enriched"	"Detected in some"	13	"neutrophil: 48.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 48.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favourable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavourable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	122.8	29.3	0.3	12.7	0.8	2.4	55.6	0.6	0.7	15.9	14.0	1.1	5.3	1.4	10.7	22.3	23.7	17.1	9.3	18.7	0.5	0.3	10.8	71.7	27.5	49.4	1.7	0.2	17.8	13.3	12.0	35.1	45.0	6.4	25.8	3.9	4.9	14.6	4.6	22.1	10.5	5.2	13.9	1.8	5.3	5.7	27.3	0.4	0.4	40.9	8.4	5.2	28.4	26.3	0.0	0.3	48.9	3.8	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	38.4	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.0	3.0	0.0	0.2	0.0	0.0	0.1	0.1	51.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.6	0.7	0.5	0.3	1.7	0.2	6.4	0.4
TBC1D3G		ENSG00000260287	"TBC1 domain family member 3G"	Q6DHY5	17	36323884-36334759	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	10	"testis: 8.7"	"Group enriched"	"Detected in some"	35	"SiHa: 5.4;U-2197: 1.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Supported		Approved	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "					"unprognostic (4.41e-1)"					"unprognostic (1.17e-2)"				"unprognostic (5.01e-2)"				0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	8.7			0.0		0.0	0.0		0.0	0.0	0.5	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.1										
TBC1D3K		ENSG00000273513	"TBC1 domain family member 3K"	A0A087X1G2	17	37924415-37935365	"Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 1.3;skeletal muscle: 1.1;testis: 4.2"	"Group enriched"	"Detected in some"	5	"SiHa: 2.2;T-47d: 5.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles		"HPA046969: , HPA047745: , HPA052553: "																		0.0	0.0		0.0		0.5	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.2	1.3			0.6	0.0	0.1		0.0		0.0	0.0		0.0	0.0	1.1	0.0	0.0	0.0		0.0	0.0	4.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
ZFR2	KIAA1086	ENSG00000105278	"Zinc finger RNA binding protein 2"	Q9UPR6	19	3804024-3869032	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.0;pituitary gland: 19.8;testis: 20.3"	"Group enriched"	"Detected in some"	12	"HMC-1: 17.4;NTERA-2: 29.9;SiHa: 8.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043275, HPA055678"	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm		"HPA043275: , HPA055678: "	"unprognostic (1.74e-3)"	"unprognostic (2.32e-3)"	"unprognostic (4.05e-3)"	"unprognostic (1.51e-2)"	"unprognostic (6.60e-3)"	"unprognostic (5.47e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.18e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.58e-1)"	"unprognostic (3.58e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.18e-2)"	1.0	6.8	13.0	1.2	17.0	1.3	1.3	2.2	16.9	1.5	0.9	1.9	0.0	0.9	0.9	0.8	0.8	2.4	1.2	1.1	7.6	12.2	0.9	0.9	1.4	1.1	4.9	10.9	1.0	1.7	0.8	19.8	0.8	7.4	1.3	1.0	5.7	1.2	1.1	0.9	1.2	1.4	0.8	3.9	1.3	1.3	20.3	2.3	0.0	1.2	0.0	1.4	0.8	0.2	0.9	0.2	1.5	0.2	1.7	4.5	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	29.9	0.0	0.0	0.0	0.0	1.4	0.0	1.0	0.6	8.8	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	1.5	0.2	0.2	3.4	0.0	4.5	0.2	2.6	1.9	0.0	0.9	3.9	3.4	0.5	1.7	0.0	0.2	0.8	1.4	13.0	17.0	2.2	15.0	7.6	12.2	4.9	10.9	7.4	2.3
ZNF541	DKFZp434I1930	ENSG00000118156	"Zinc finger protein 541"	Q9H0D2	19	47520685-47555856	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 17.7"	"Group enriched"	"Detected in some"	5	"HEL: 3.1;SiHa: 10.0;U-87 MG: 3.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.7"					"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA058541, HPA076453"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA058541: , HPA076453: "	"unprognostic (4.49e-2)"	"prognostic favourable (2.94e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.92e-5)"	"unprognostic (7.98e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.52e-2)"	"unprognostic (3.09e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-2)"	1.2	2.6	0.1	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.4			0.1	0.1	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.9	0.0	0.1	0.1	0.0		2.2	0.0	0.0	0.4	0.3		0.0	0.0		0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.5	0.0	17.7			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.1	0.0	0.5	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	1.0	0.2	0.2	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0